N8 Medical N8 Medical
N8 Medical N8 Medical
  • Home
  • About Us
  • Leadership
  • News
  • Pipeline
  • Publications

August 2018

N8 Medical > News > 2018 > August

N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope

August 7, 2018 2:00 amAugust 27, 2018

CeraShield™ resorbable envelope targets prevention of bacterial and highly lethal fungal infections and reduction of surgical site infections of pacemaker implantations

Read more

N8 Medical News

Here you will find the latest information, including: press releases, events and presentations and blog posts.

Newsletter Sign-up

Interested in hearing whats new with N8 Medical? Sign-up to join our newsletter.

Recent Posts

  • N8 Medical and USAMRIID Enter CRADA to Test CSA Compounds Against Anthrax and other Biodefense Pathogens
  • FDA grants QIDP Designation For Kinnear’s CSA-131 drug for Life-threatening Pseudomonas Bacterial Infections in CF
  • NIH Awards N8 Medical Two Additional SBIR Grants to Develop CeraShieldTM Coated Hemodialysis Catheters and Pedicle Screws
  • N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant
  • N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

N8 Medical, LLC

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.
The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.
 
  • Home
  • Overview
  • Leadership
  • News
  • Technology
  • Pipeline
  • Publications

© 2019-2023 N8 Medical, LLC. All Rights Reserved. Privacy Policy

Menu
  • Home
  • About Us
  • Leadership
  • News
  • Pipeline
  • Publications